Home / 2021 / May / 22

Daily Archives: May 22, 2021

Bharat Parenterals gets DCGI nod for favipiravir oral suspension

Bharat Parenterals gets DCGI nod for favipiravir oral suspension

Drug firm on Saturday said it has received approval from the Drugs Controller General of India (DCGI) for favipiravir oral suspension, to be used for treatment of COVID-19 patients. The company has received licence and authorisation from DCGI to manufacture and market favipiravir oral suspension l00mg/ml, Bharat Parenterals said in …

Read More »

PathAI, which develops AI-powered technology for disease diagnosis and treatment, raises $165M Series C led by D1 Capital Partners and Kaiser Permanente (Andrea Park/FierceBiotech)

PathAI, which develops AI-powered technology for disease diagnosis and treatment, raises 5M Series C led by D1 Capital Partners and Kaiser Permanente (Andrea Park/FierceBiotech)

Andrea Park / FierceBiotech: PathAI, which develops AI-powered technology for disease diagnosis and treatment, raises $165M Series C led by D1 Capital Partners and Kaiser Permanente  —  If its hundreds of millions in venture funding and wide-ranging cadre of big-named partners are any indication, PathAI’s (ahem) path forward appears to …

Read More »